摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-benzylidene-2-chlorobenzenamine oxide | 71013-75-7

中文名称
——
中文别名
——
英文名称
N-benzylidene-2-chlorobenzenamine oxide
英文别名
N-(2-chlorophenyl)-α-phenylnitrone;α-phenyl-N-2-chlorophenylnitrone;N-(2-Chlorophenyl)(phenyl)methanimine N-oxide;N-(2-chlorophenyl)-1-phenylmethanimine oxide
N-benzylidene-2-chlorobenzenamine oxide化学式
CAS
71013-75-7
化学式
C13H10ClNO
mdl
——
分子量
231.681
InChiKey
MDAMGDYJLNAGFL-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.3
  • 重原子数:
    16
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    28.8
  • 氢给体数:
    0
  • 氢受体数:
    1

SDS

SDS:e86443c3669741a81e855643c5df10bb
查看

反应信息

  • 作为反应物:
    描述:
    N-benzylidene-2-chlorobenzenamine oxide 在 sodium tetrahydroborate 作用下, 以 甲醇 为溶剂, 反应 1.0h, 以0.795 g的产率得到N-benzyl-N-(2-chlorophenyl)hydroxylamine
    参考文献:
    名称:
    Synthesis of 3-Alkylbenzoxazolones from N-Alkyl-N-arylhydroxylamines by Contiguous O-Trichloroacetylation, Trichloroacetoxy ortho-Shift, and Cyclization Sequence
    摘要:
    Benzoxazolone pharmacophore is present in clinical pharmaceuticals, drug candidates, and many compounds having a wide spectrum of biological activities. The methods available for the synthesis of benzoxazolones have limited diversity due to problems in accessibility and air-sensitivity of diversely substituted o-aminophenols from which they are generally prepared by cyclocarbonylation with phosgene or its equivalents. The present paper describes a mild method for the synthesis of 3-alkylbenzoxazolones from easily accessible and air-stable nitroarenes. Nitroarenes were converted to N-alkyl-N-arylhydroxylamines in two steps involving partial reduction to arylhydroxylamines followed by selective N-alkylation. Treatment of N-alkyl-N-arylhydroxylamines with trichloroacetyl chloride and triethylamine afforded 3-alkylbenzoxazolones generally in good yields through an uninterrupted three-step sequence involving O-trichloroacetylation, N -> C-ortho trichloroacetoxy shift, and cyclization in a single pot at ambient temperatures. The present method is mild, wide in scope, economical, and regioselective. Many sensitive groups like alkyl and aryl esters, amide, cyano, and the carbon-carbon double bond survive the reaction.
    DOI:
    10.1021/jo401985h
  • 作为产物:
    描述:
    2-氯苯基羟胺苯甲醛乙醇 为溶剂, 以to give α-phenyl-N-2-chlorophenylnitrone的产率得到N-benzylidene-2-chlorobenzenamine oxide
    参考文献:
    名称:
    Method of treating inflammation
    摘要:
    α-苯基-N-苯基亚硝基甲烷及其衍生物通过局部给药缓解炎症和相关疼痛和发热。
    公开号:
    US04197314A1
点击查看最新优质反应信息

文献信息

  • Synthesis of Exclusively 4-Substituted β-Lactams through the Kinugasa Reaction Utilizing Calcium Carbide
    作者:Abolfazl Hosseini、Peter R. Schreiner
    DOI:10.1021/acs.orglett.9b01192
    日期:2019.5.17
    A new Kinugasa reaction protocol has been elaborated for the one-pot synthesis of 4-substituted β-lactams utilizing calcium carbide and nitrone derivatives. Calcium carbide is thereby activated by TBAF·3H2O in the presence of CuCl/NMI. The ease of synthesis and use of inexpensive chemicals provides rapid access of practical quantities of β-lactams exclusively substituted at position 4.
    已经详细阐述了一种新的Kinugasa反应方案,用于利用电石和硝酮衍生物一锅合成4-取代的β-内酰胺。因此,在CuCl / NMI存在下,碳化钙被TBAF·3H 2 O活化。易于合成和使用廉价的化学药品,可快速获得仅在第4位被取代的实用数量的β-内酰胺。
  • Highly Regio- and Stereoselective Dirhodium Vinylcarbene Induced Nitrone Cycloaddition with Subsequent Cascade Carbenoid Aromatic Cycloaddition/NO Cleavage and Rearrangement
    作者:Xiaochen Wang、Quentin M. Abrahams、Peter Y. Zavalij、Michael P. Doyle
    DOI:10.1002/anie.201201917
    日期:2012.6.11
    An abnormal cascade process provides a selective method for the preparation of tricyclic heterocycles. The cascade involves a metal carbene induced regioselective [3+2] cycloaddition, a Buchner reaction, and a [1,7]‐oxygen migration, which occurs with NO cleavage (see scheme). The products are formed with remarkable specificity.
    异常的级联过程提供了制备三环杂环的选择性方法。级联涉及诱导区域选择性[3 + 2]环加成的属卡宾,布氏反应,和[1,7] -氧迁移,这与N-发生 ø裂解(参见方案)。产物具有明显的特异性。
  • Asymmetric Synthesis of<i>trans</i>-β-Lactams by a Kinugasa Reaction on Water
    作者:Zhenling Chen、Lili Lin、Min Wang、Xiaohua Liu、Xiaoming Feng
    DOI:10.1002/chem.201204373
    日期:2013.6.3
    The asymmetric Kinugasa reaction was performed on pure water for the first time without the need for any organic co‐solvents. In contrast to most asymmetric Kinugasa reactions, trans‐β‐lactams were obtained as the major products in good yields, enantioselectivities, and diastereoselectivities (up to 90 % yield, 98 % ee, and >99:1 d.r.). This reaction is atom‐economical, environmentally friendly, and
    首次在纯上进行不对称的Kinugasa反应,不需要任何有机助溶剂。与大多数不对称的Kinugasa反应相反,反式-β-内酰胺是主要产物,具有良好的收率,对映选择性和非对映选择性(最高90%收率,98%ee和> 99:1 dr)。该反应是原子经济的,环境友好的,并提供了合成有用但具有挑战性的产品。
  • Method of treatment
    申请人:William H. Rorer, Inc.
    公开号:US04153722A1
    公开(公告)日:1979-05-08
    This invention describes a method of treating inflammation in warmblooded animals by topically administering an effective amount of .alpha.-phenyl-N-phenylnitrone and derivatives thereof.
    本发明描述了一种通过局部给予有效量的α-苯基-N-苯基硝基酮及其衍生物来治疗温血动物炎症的方法。
  • Anti-inflammatory compositions containing .alpha.-phenyl-N-phenylnitrone
    申请人:William H. Rorer, Inc.
    公开号:US04224340A1
    公开(公告)日:1980-09-23
    This invention relates to novel compositions containing .alpha.-phenyl-n-phenylnitrone compounds which are useful for the topical treatment of inflammation in warm-blooded animals.
    本发明涉及一种新型组合物,其中包含对于温血动物的局部治疗炎症有用的α-苯基-N-苯基亚硝基化合物
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫